Kidney Disease After COVID-19

CompletedOBSERVATIONAL
Enrollment

1,753

Participants

Timeline

Start Date

January 4, 2020

Primary Completion Date

January 4, 2024

Study Completion Date

January 4, 2024

Conditions
COVID-19Acute Kidney InjuryChronic Kidney Injury
Trial Locations (5)

10029

Icahn School of Medicine at Mount Sinai, New York

21287

Johns Hopkins University, Baltimore

48105

University of Michigan, Ann Arbor

06513

Yale School of Medicine, New Haven

07103

New Jersey Medical School - Rutgers University, Newark

All Listed Sponsors
collaborator

New Jersey Medical School

OTHER

collaborator

University of Michigan

OTHER

collaborator

Yale New Haven Health System Center for Healthcare Solutions

OTHER

collaborator

Johns Hopkins University

OTHER

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT05328986 - Kidney Disease After COVID-19 | Biotech Hunter | Biotech Hunter